# TAFLUPROST
> **ANDA209040** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2022-01-28
## Drug
- **FDA Application Number:** ANDA209040
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TAFLUPROST
- **Generic name:** TAFLUPROST
- **Active ingredients:** TAFLUPROST
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ
- **Manufacturer:** Sandoz Inc
- **First approval:** 2022-01-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209040)
---
*MORVS · CC0 1.0*